miRNAs have been well studied for their potential use as osteoporosis biomarkers in previous studies [60,61,62,63], but in the case of the treatment of osteoporosis with PTH, only two studies have been conducted in terms of determining a potential circulating biomarker [15,26]. Here, PTH is linked to osteoporosis.